Biolase Inc (NASDAQ:BIOL) traded at $0.14 at close of the session on Monday, March 18, made an upward move of 1.51% on its previous day’s price.
Looking at the stock we see that its previous close was $0.14 and the beta (5Y monthly) reads 0.87 . In terms of its 52-week price range, BIOL has a high of $47.10 and a low of $0.13. The company’s stock has lost about -2.96% over that past 30 days.
Biolase Inc has a market cap of $4.34 million and is expected to release its quarterly earnings report on Mar 26, 2024 – Apr 01, 2024.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the BIOL stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell. Long term indicators on average place the stock in the category of 100% Sell.
Looking further, we note the current price level is -0.96% off its SMA20 and -72.96% from its 50-day simple moving average. The RSI (14) is pointing at 25.22 while the volatility over the past week is 6.63% and jumps to 7.27% over the past one month. The beta value is 0.62, while the average true range (ATR) is currently pointing at 0.03.
Coming back to Biolase Inc (NASDAQ:BIOL), we note that the average 3-month trading volume was 2.22 million, while that of the preceding 10-day period stands at 2.09 million.
The insiders hold 5.64% of the company’s shares while institutions hold 4.83%. The data shows that short shares as of Feb 29, 2024, stood at 0.25 million at a short ratio of 0.06. This represents a 1.28% short interest in shares outstanding on Feb 29, 2024. Shares short rose in February from the previous month at 96560.0. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -87.43% down in year-to-date price movement.
